Skip to main content
logo
Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,415.00
+185.00 (4.37%)
At close: Aug 20, 2026

Genome & Company Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
230,902238,38485,207176,209245,897468,827
Market Cap Growth
186.79%179.77%-51.64%-28.34%-47.55%-55.28%
Enterprise Value
210,902227,51189,070151,242185,907383,841
Last Close Price
4415.006880.002750.006245.008725.0017350.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.619.703.0712.3317.461038.96
PB Ratio
2.022.080.861.551.634.13
P/TBV Ratio
2.732.833.404.833.738.10

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.789.253.2110.5813.20850.63

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.240.170.320.230.040.06
Net Debt / Equity Ratio
-0.29-0.16-0.49-0.53-0.67-0.62
Net Debt / EBITDA Ratio
1.510.792.921.282.092.10
Net Debt / FCF Ratio
1.710.962.411.171.992.42
Asset Turnover
0.150.170.180.090.090.00
Inventory Turnover
1.621.902.593.534.76-
Quick Ratio
1.201.902.803.099.838.03
Current Ratio
1.492.313.083.3610.498.32
Return on Equity (ROE)
-7.13%-7.20%-25.26%-38.36%-43.15%-31.51%
Return on Assets (ROA)
-11.33%-12.50%-9.78%-20.55%-23.17%-17.48%
Return on Capital Employed (ROCE)
-23.50%-23.90%-20.60%-41.40%-35.50%-28.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.47%-2.70%-23.60%-26.94%-21.08%-7.28%
FCF Yield
-8.51%-7.83%-23.82%-28.99%-20.50%-6.19%
Buyback Yield / Dilution
-4.79%-2.75%-7.91%-0.32%-4.71%-39.60%